Article
Binding of warfarin, salicylate, and diazepam to genetic variants of human serum albumin with known mutations.
Molecular pharmacology - 1 Feb 1990
Kragh-Hansen U, Brennan S O, Galliano M, Sugita O
Abstract excerpt
Possible effects of single point mutations on the ligand-binding capabilities of human serum albumin (Alb) were investigated by studying the interactions between the strongly bound drugs warfarin, salicylate, and diazepam and five structurally characterized genetic variants of the protein. Equilibrium dialysis data, obtained with the variants and normal serum Alb, revealed pronounced reductions in high affinity...
Topics
- Binding Sites
- Dialysis
- Diazepam
- Humans
- Mutation
- Protein Binding
- Radioligand Assay
- Salicylates
- Salicylic Acid
- Serum Albumin
- Structure-Activity Relationship
